Differences between a drug regimen employed in early phase 1 trials and the subsequent use of the agent in routine oncologic practice: a note of caution. [electronic resource]
Producer: 20071113Description: 1644-7 p. digitalISSN:- 0008-543X
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.